Arcus Biosciences, Inc.
Arcus Biosciences, Inc. (RCUS) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 312 transactions totaling $589.6M, demonstrating a bullish sentiment with $543.5M in net insider flow. The most recent transaction on Jan 23, 2026 involved a transaction of 126,000 shares valued at $0.
RCUS Insider Activity Summary
Who Is Buying RCUS Stock?
No significant insider buying has been recorded for RCUS in the recent period.
Who Is Selling RCUS Stock?
No significant insider selling has been recorded for RCUS in the recent period.
Is Arcus Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for RCUS is bullish with an Insider Alignment Score of 96/100 and a net flow of $543.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
RCUS Frequently Asked Questions
Understanding RCUS Insider Activity
Insider trading at Arcus Biosciences, Inc. (RCUS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading RCUS stock, having executed 312 transactions in the past 90 days. The most active insider is Sciences, Inc. Gilead (Executive), who has made 2 transactions totaling $339.5M.
Related Tools
Track Arcus Biosciences, Inc. Insider Activity
Get notified when executives and directors at RCUS file new Form 4 transactions